Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 4.2% – Here’s Why

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) shares rose 4.2% during mid-day trading on Tuesday . The stock traded as high as $26.50 and last traded at $26.50. Approximately 1,429 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 4,868 shares. The stock had previously closed at $25.42.

Analyst Upgrades and Downgrades

AFJK has been the topic of several research analyst reports. Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Friday, March 27th. Wall Street Zen raised shares of Aimei Health Technology to a “sell” rating in a research report on Saturday, January 17th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Aimei Health Technology has a consensus rating of “Sell”.

Aimei Health Technology Price Performance

The business’s 50-day moving average price is $35.27 and its 200 day moving average price is $30.49. The firm has a market capitalization of $162.18 million, a price-to-earnings ratio of 126.20 and a beta of -1.48.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in AFJK. Berkley W R Corp lifted its position in shares of Aimei Health Technology by 23.6% during the second quarter. Berkley W R Corp now owns 425,361 shares of the company’s stock worth $4,704,000 after purchasing an additional 81,235 shares in the last quarter. Clear Street Group Inc. acquired a new position in shares of Aimei Health Technology during the third quarter worth $691,000. Quarry LP lifted its position in shares of Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after purchasing an additional 10,000 shares in the last quarter. Geode Capital Management LLC acquired a new position in shares of Aimei Health Technology during the fourth quarter worth $413,000. Finally, Dakota Wealth Management acquired a new position in shares of Aimei Health Technology during the fourth quarter worth $406,000. 45.58% of the stock is owned by institutional investors and hedge funds.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.